Combined haemostatic defects in family members of symptomatic carriers of FV Leiden mutation;ZŁozone defekty hemostazy w rodzinach nosicieli mutacji typu Leiden genu czynnika V

Polskie Archiwum Medycyny Wewnetrznej

Volumn 99, Issue 3, 1998, Pages 211-217

  Andowski, Krzysztof Lew ^a,c   Rozek, Marek ^b   Turowiecka, Zofia ^a   Markiewicz, Wojciech Tadeusz ^b   Zawilska, Krystyna ^a  

^a Klinika Hematologii   (Poland)

^b POLISH ACADEMY OF SCIENCES   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Combined haemostatic defects; Familial thrombophilia; FV Leiden mutation

Indexed keywords

BLOOD CLOTTING FACTOR 5; PROTHROMBIN;

ANTITHROMBIN III DEFICIENCY; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; GENETICS; HETEROZYGOTE; HUMAN; MALE; MIDDLE AGED; MUTATION; PEDIGREE; THROMBOPHLEBITIS;

ANTITHROMBIN III DEFICIENCY; BLOOD COAGULATION DISORDERS; DISEASE-FREE SURVIVAL; FACTOR V; FEMALE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PROTHROMBIN; THROMBOPHLEBITIS;

EID: 0032015756     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Egeberg O.: Inherited antithrombin deficiency causing thrombophilia. Thromb. Diathes. Haemorrh., 1965, 13, 516.
2. Rodeghiero F., Tosetto A.: The epidemiology of inherited thrombophilia: the VITA project. Thromb. Haemost., 1997, 78, 636.
3. 506allele, and venous thrombosis. Ann. Haematol., 1996, 72, 166.
4. Dahlbäck B., Hildebrand B.: Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc. Natl. Acad. Sci. USA, 1994, 91, 1396.
5. Koster T., Rosendaal F.R., de Ronde H., Briet E., Vandenbroucke J.P., Bertina R.M.: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet, 1993, 342, 1503.
6. Poort S.R., Rosendaal F.R., Reitsma P.H , Bertina R.M.: A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 1996, 88, 3698.
7. Pabinger I., Brucker S., Kyrle P. i wsp.: Hereditary deficiency of antithrombin III, protein C and protein S: Prevalence in patients with a history of venous thrombosis and criteria for rational patient screening. Blood Coagul. Fibrinolysis. 1992, 3, 547.
8. Łopaciuk S., Bykowska K., Filipecki S.: Wrodzony niedobór antytrombiny III, białka Club białka S jako czynnik ryzyka żylnej choroby zakrzepowo-zatorowej. Przegl. Chir., 1993, 65, 890.
9. Ridker P.M., Hennekens C.H., Lindpainter K., Stampfer M.J., Eisenberg P.R., Miletich J.P.: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. New Engl. J. Med., 1995, 332, 912.
10. Rosendaal F.R., Koster T., Vandenbroucke J.P., Reitsma P.H.: High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood, 1995, 85, 1504.
11. Pabinger I., Schneider B. & GTH Study Group on Natural Inhibitors: Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S- deficiency taking oral contraceptive medication. Thromb. Haemost., 1994, 71, 548.
12. Pabinger I., Kyrle P.A., Heistinger M., Eichinger S., Wittmann E., Lechner K.: The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: a prospective cohort study. Thromb. Haemost., 1994, 71, 441.
13. Finazzi G., Barbui T.: Different incidence of venous thrombosis in patients with inherited deficiences of antithrombin III, protein C and protein S. Thromb. Haemostas., 1994, 71, 15.
14. Brenner B., Ziovelin A., Lanir N., Greengard J.S., Griffin J.H., Seligsohn U.: Venous thromboembolism associated with double heterozygosity for R506Q mutation in factor V and for T298 mutation of protein C in a large family of a previously described homozygous protein C - deficient newborn with massive thrombosis. Blood, 1996, 88, 877.
15. Gandrille S., Jude B., Alhenic-Gelas M., Millaire A. & Aiach M.: Compound heterozygosity in a family with protein C deficiency illustrating the complexity of the underlying molecular mechanism. Thromb. Haemost., 1993, 70, 747.
16. Soria J-M., Morell M., Jimenez-Astorga C., Estivill X., Sala N.: Severe type I protein C deficiency in an compound heterozygote for Y124C and Q132X mutation in exon 6 of the PROC gene. Thromb. Haemost., 1995, 74, 1215.
17. Jobin F., Vu L., Lessard M.: Two cases of inherited triple deficiency in a large kindred with thrombotic diathesis and deficiencies of antithrombin III, heparin cofactor II, protein C and S. Thromb. Haemost., 1991, 66, 295.
18. Koeleman B.P.C., Reitsma P.H., Allaart C.F., Bertina R.M.: Activated protein C resistance as an additional risk factor for thrombosis in protein C deficient families. Blood, 1994, 84, 1031.
19. Lewandowski K., Turowiecka Z., Rożek M., Markiewicz W.T., Zawilska K.: Cze+ (combining ogonek sign)stość mutacji Leiden genu czynnika V u chorych na żylna+ (combining ogonek sign) chorobe+ (combining ogonek sign) zakrzepowo-zatorowa+ (combining ogonek sign). Acta Haematol. Pol., 1997, 28, 31.
20. Lewandowski K., Rożek M., Markiewicz W.T., Zawilska K.: An alternative method for identifying a factor V gene Leiden mutation. Thromb. Res., 1997, 85, 105.
21. Ridker P.M., Glynn R.J., Miletich P.J., Goldhaber S.Z., Stampfer M.J., Hennekens C.H.: Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann. Intern. Med., 1997, 126, 528.
22. van Boven H.H., Reitsma P.H., Rosendaal F.R. i wsp.: Factor V Leiden (FV R506Q) in families with inherited antithrombin III deficiency. Thromb. Haemost., 1996, 75, 417.
23. Koeleman B.P.C., van Rumpt D., Hamulyak K., Reitsma P.H. & Bertina R.M.: Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families. Thromb. Haemost., 1995, 74, 580.
24. Bernardi F., Legnani C., Michelleti F. i wsp.: A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects. Thromb. Haemost., 1996, 76, 505.
25. van Boven H.H., Poort S.R., Bertina R.M., Rosendaat F.R.: Contribution of aditional genetic risk factors in symptomatic antithrombin deficient individuals: FV 1691A and FII 20210A. Thromb. Haemost. 1997. suppl., 379, abstr. 1548.
26. Zöller B., He X., Dahlbäck B.: Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease. Thromb. Haemost., 1995, 73, 7434.
27. Lewandowski K., Turowiecka Z., Zozulińska M., Zawilska K.: Przeżycie wolne od zakrzepicy wśród członków wielopokoleniowej rodziny z niedoborem antytrombiny III typu I i białka S typu III. Acta Haematol. Pol., 1997 (w druku).
28. Faioni E.M., Franchi F., Asti D., Sacchi E., Bernardi F., Mannuci P.M.: Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assays. Thromb. Haemost., 1993, 70, 1067.
29. Hille E.T.M., Westendorp R.G.J., Vandenbroucke J.P., Rosendaal F.R.: Mortality and causes of death in families with the factor V Leiden mutation (resistance to activated protein C). Blood, 1997, 89, 1963.